{"id":"https://openalex.org/W2996656722","doi":"https://doi.org/10.31351/vol28iss2pp95-104","title":"Formulation and Evaluation of Sustained Release Sumatriptan Mucoadhesive Intranasal in-Situ Gel","display_name":"Formulation and Evaluation of Sustained Release Sumatriptan Mucoadhesive Intranasal in-Situ Gel","publication_year":2019,"publication_date":"2019-12-22","ids":{"openalex":"https://openalex.org/W2996656722","doi":"https://doi.org/10.31351/vol28iss2pp95-104","mag":"2996656722"},"language":"en","primary_location":{"id":"doi:10.31351/vol28iss2pp95-104","doi":"https://doi.org/10.31351/vol28iss2pp95-104","is_oa":true,"landing_page_url":"https://doi.org/10.31351/vol28iss2pp95-104","pdf_url":"https://bijps.uobaghdad.edu.iq/index.php/bijps/article/download/926/802","source":{"id":"https://openalex.org/S2764399167","display_name":"Iraqi Journal of Pharmaceutical Sciences","issn_l":"1683-3597","issn":["1683-3597","2521-3512"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310319170","host_organization_name":"University of Baghdad","host_organization_lineage":["https://openalex.org/P4310319170"],"host_organization_lineage_names":["University of Baghdad"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iraqi Journal of Pharmaceutical Sciences ( P-ISSN: 1683 - 3597 , E-ISSN : 2521 - 3512)","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://bijps.uobaghdad.edu.iq/index.php/bijps/article/download/926/802","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064741817","display_name":"Hussein K. Alkufi","orcid":"https://orcid.org/0000-0001-6977-6737","observed_orcids":["https://orcid.org/0000-0001-6977-6737"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hussein K. Alkufi","raw_affiliation_strings":["pharmacetics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"pharmacetics","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040264157","display_name":"Hanan Jalal Kassab","orcid":"https://orcid.org/0000-0001-9590-339X","observed_orcids":["https://orcid.org/0000-0001-9590-339X"]},"institutions":[{"id":"https://openalex.org/I135120706","display_name":"University of Baghdad","ror":"https://ror.org/007f1da21","country_code":"IQ","type":"education","lineage":["https://openalex.org/I135120706"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Hanan J. Kassab","raw_affiliation_strings":["College of Pharmacy, University of Baghdad"],"raw_orcid":"https://orcid.org/0000-0001-9590-339X","affiliations":[{"raw_affiliation_string":"College of Pharmacy, University of Baghdad","institution_ids":["https://openalex.org/I135120706"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":250000,"currency":"IQD","value_usd":null},"apc_paid":null,"fwci":0.3312,"has_fulltext":true,"cited_by_count":42,"citation_normalized_percentile":{"value":0.49347939,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"28","issue":"2","first_page":"95","last_page":"104"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10343","display_name":"Hydrogels: synthesis, properties, applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sumatriptan","display_name":"sumatriptan","score":1.0},{"id":"https://openalex.org/keywords/in-situ-gel","display_name":"in situ gel","score":0.7919999957084656},{"id":"https://openalex.org/keywords/migraine-treatment","display_name":"migraine treatment","score":0.6240000128746033},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.8159999847412109},{"id":"https://openalex.org/keywords/pluronic-f127","display_name":"Pluronic F127","score":0.9490000009536743},{"id":"https://openalex.org/keywords/poloxamer-188","display_name":"poloxamer 188","score":1.0},{"id":"https://openalex.org/keywords/hyaluronic-acid","display_name":"hyaluronic acid","score":0.9919999837875366},{"id":"https://openalex.org/keywords/thermoresponsive-polymers","display_name":"thermoresponsive polymers","score":0.9570000171661377},{"id":"https://openalex.org/keywords/nasal-permeation","display_name":"nasal permeation","score":0.6790000200271606},{"id":"https://openalex.org/keywords/ex-vivo-permeation","display_name":"ex vivo permeation","score":0.527999997138977},{"id":"https://openalex.org/keywords/cold-method","display_name":"cold method","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C2780306666","wikidata":"https://www.wikidata.org/wiki/Q7225971","display_name":"Poloxamer 407","level":5,"score":0.827966570854187},{"id":"https://openalex.org/C101335993","wikidata":"https://www.wikidata.org/wiki/Q408943","display_name":"Poloxamer","level":4,"score":0.714836061000824},{"id":"https://openalex.org/C85663871","wikidata":"https://www.wikidata.org/wiki/Q6966562","display_name":"Nasal administration","level":2,"score":0.6940327882766724},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.5842589139938354},{"id":"https://openalex.org/C50670333","wikidata":"https://www.wikidata.org/wiki/Q907651","display_name":"Permeation","level":3,"score":0.549190878868103},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5208207368850708},{"id":"https://openalex.org/C201253974","wikidata":"https://www.wikidata.org/wiki/Q1330121","display_name":"First pass effect","level":3,"score":0.5147021412849426},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4873090982437134},{"id":"https://openalex.org/C205679159","wikidata":"https://www.wikidata.org/wiki/Q3375179","display_name":"Transdermal","level":2,"score":0.48388752341270447},{"id":"https://openalex.org/C2781220964","wikidata":"https://www.wikidata.org/wiki/Q416694","display_name":"Gellan gum","level":2,"score":0.4829382300376892},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44745558500289917},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.4447571635246277},{"id":"https://openalex.org/C2780020223","wikidata":"https://www.wikidata.org/wiki/Q25323681","display_name":"Mucoadhesion","level":4,"score":0.42174068093299866},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.3439438045024872},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.32035642862319946},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24123743176460266},{"id":"https://openalex.org/C13245373","wikidata":"https://www.wikidata.org/wiki/Q3715494","display_name":"Drug carrier","level":3,"score":0.18882498145103455},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.18060237169265747},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06722652912139893},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0626397430896759},{"id":"https://openalex.org/C15920480","wikidata":"https://www.wikidata.org/wiki/Q421281","display_name":"Copolymer","level":3,"score":0.0},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.0},{"id":"https://openalex.org/C31903555","wikidata":"https://www.wikidata.org/wiki/Q1637030","display_name":"Food science","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.31351/vol28iss2pp95-104","doi":"https://doi.org/10.31351/vol28iss2pp95-104","is_oa":true,"landing_page_url":"https://doi.org/10.31351/vol28iss2pp95-104","pdf_url":"https://bijps.uobaghdad.edu.iq/index.php/bijps/article/download/926/802","source":{"id":"https://openalex.org/S2764399167","display_name":"Iraqi Journal of Pharmaceutical Sciences","issn_l":"1683-3597","issn":["1683-3597","2521-3512"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310319170","host_organization_name":"University of Baghdad","host_organization_lineage":["https://openalex.org/P4310319170"],"host_organization_lineage_names":["University of Baghdad"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iraqi Journal of Pharmaceutical Sciences ( P-ISSN: 1683 - 3597 , E-ISSN : 2521 - 3512)","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:063145844c91490aac7c52c4a7bc3bb5","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/063145844c91490aac7c52c4a7bc3bb5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Iraqi Journal of Pharmaceutical Sciences, Vol 28, Iss 2, Pp 95-104 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.31351/vol28iss2pp95-104","doi":"https://doi.org/10.31351/vol28iss2pp95-104","is_oa":true,"landing_page_url":"https://doi.org/10.31351/vol28iss2pp95-104","pdf_url":"https://bijps.uobaghdad.edu.iq/index.php/bijps/article/download/926/802","source":{"id":"https://openalex.org/S2764399167","display_name":"Iraqi Journal of Pharmaceutical Sciences","issn_l":"1683-3597","issn":["1683-3597","2521-3512"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310319170","host_organization_name":"University of Baghdad","host_organization_lineage":["https://openalex.org/P4310319170"],"host_organization_lineage_names":["University of Baghdad"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iraqi Journal of Pharmaceutical Sciences ( P-ISSN: 1683 - 3597 , E-ISSN : 2521 - 3512)","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2996656722.pdf","grobid_xml":"https://content.openalex.org/works/W2996656722.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W81914535","https://openalex.org/W206378795","https://openalex.org/W1156381026","https://openalex.org/W1794575150","https://openalex.org/W1966590541","https://openalex.org/W1968845856","https://openalex.org/W1992814088","https://openalex.org/W1996262004","https://openalex.org/W2013645301","https://openalex.org/W2046821342","https://openalex.org/W2052526822","https://openalex.org/W2083153400","https://openalex.org/W2085587616","https://openalex.org/W2104347910","https://openalex.org/W2109991259","https://openalex.org/W2147963493","https://openalex.org/W2163287967","https://openalex.org/W2252362954","https://openalex.org/W2286445807","https://openalex.org/W2493475775","https://openalex.org/W2594021464","https://openalex.org/W2615075788","https://openalex.org/W2724658686","https://openalex.org/W2887900500","https://openalex.org/W2900942562","https://openalex.org/W4233602835","https://openalex.org/W4302382661","https://openalex.org/W6600548499","https://openalex.org/W6816643093"],"related_works":["https://openalex.org/W4405073087","https://openalex.org/W7217168963","https://openalex.org/W4392715232","https://openalex.org/W4402534852","https://openalex.org/W4393672560","https://openalex.org/W1156381026","https://openalex.org/W7216148706","https://openalex.org/W2046821342","https://openalex.org/W7219315126","https://openalex.org/W3024699289"],"abstract_inverted_index":{"Sumatriptan(ST)":[0],"is":[1,15],"a":[2,23,82,213],"selective":[3],"agonist":[4],"at":[5],"serotonin":[6],"5-HTI":[7],"receptors,":[8],"as":[9,11,212],"well":[10],"5-HT1B/1D":[12],"subtypes.":[13],"It":[14],"effective":[16],"for":[17,56,91,140],"acute":[18],"migraine":[19,57],"attacks,":[20],"but":[21],"has":[22],"short":[24],"half":[25],"life":[26],"(about":[27],"2":[28],"hours)":[29],"and":[30,43,94,110,123,155,199,204,222,230],"low":[31],"oral":[32],"bioavailability":[33],"(15%).":[34],"The":[35],"purpose":[36],"of":[37,49,67,130,210,224],"this":[38],"study":[39,181,187],"was":[40,61,114],"to":[41,51,63,116,124,217],"develop":[42],"optimize":[44],"nasal":[45,53,69,137,196,214],"mucoadhesive":[46,83,103,169],"in-situ":[47],"gel(IG)":[48],"ST":[50,68,136,211],"enhance":[52,235],"residence":[54],"time":[55],"management.":[58],"Cold":[59],"method":[60],"used":[62],"prepare":[64],"different":[65],"formulas":[66],"IG,":[70],"using":[71],"thermosensitive":[72],"polymers":[73],"(poloxamer":[74],"407":[75],"alone":[76],"or":[77,191],"with":[78,81,188,227],"poloxamer":[79,151],"188)":[80],"polymer":[84],"hyaluronic":[85],"acid":[86],"(HA)":[87],"which":[88],"were":[89],"examined":[90],"gelation":[92,95,161],"temperature":[93,162],"time,":[96],"pH,":[97],"drug":[98,108,174,203,232],"content,":[99],"gel":[100,138,164,216],"strength,":[101],"spreadability,":[102],"force":[104,170],"determination,":[105],"viscosity,":[106],"in-vitro":[107,173],"release,":[109,233],"the":[111,131,146,184,195],"selected":[112],"formula":[113,147],"subjected":[115],"fourier":[117],"transform":[118],"infrared":[119],"(FTIR)":[120],"compatibility":[121],"studies,":[122],"ex-vivo":[125,179],"permeation":[126,180],"study,":[127],"histological":[128,190],"evaluation":[129],"sheep":[132,197],"mucosal":[133],"tissue":[134,198],"after":[135],"application":[139],"6":[141,185],"hours.The":[142],"results":[143],"showed":[144],"that":[145],"IG7":[148],"prepared":[149],"from":[150],"407(19%),":[152],"poloxamer188":[153],"(4%)":[154],"HA":[156],"(0.5%)":[157],"had":[158],"an":[159],"optimum":[160],"(32.66\u00b11.52\u00b0C),":[163],"strength":[165],"(43.66\u00b1":[166],"1.52":[167],"sec),":[168],"(8067.93\u00b1":[171],"746.45dyne\\cm2),":[172],"release":[175],"(95.98%)":[176],"over":[177],"6h,":[178],"(89.6%)":[182],"during":[183],"h.":[186],"no":[189,200],"pathological":[192],"change":[193],"in":[194,207],"interaction":[201],"between":[202],"other":[205],"additives":[206],"IG7.":[208],"Formulation":[209],"insitu":[215],"avoid":[218],"first":[219],"pass":[220],"metabolism":[221],"ease":[223],"administration":[225],"coupled":[226],"less":[228],"frequent":[229],"sustained":[231],"will":[234],"patient":[236],"compliance.":[237]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":15},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2019-12-26T00:00:00"}